Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Adorini

Showing results (201-210 of 204) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 204 results.
Frontiers in Cardiovascular Medicine|December 18, 2024
Protective effect of UDCA against IL-11- induced cardiac fibrosis is mediated by TGR5 signallingB Reilly-O'Donnell, E Ferraro, R Tikhomirov, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2001
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regenerationG Condorelli, U Borello, L De Angelis, et al.
Plos One|January 25, 2019
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinomaS Di Matteo, L Nevi, D Costantini, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 17, 2017
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progressionO Erice, I Labiano, A Arbelaiz, et al.
Pageof 21

Showing results (201-210 of 204) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 204 results.
Frontiers in Cardiovascular Medicine|December 18, 2024
Protective effect of UDCA against IL-11- induced cardiac fibrosis is mediated by TGR5 signallingB Reilly-O'Donnell, E Ferraro, R Tikhomirov, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2001
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regenerationG Condorelli, U Borello, L De Angelis, et al.
Plos One|January 25, 2019
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinomaS Di Matteo, L Nevi, D Costantini, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 17, 2017
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progressionO Erice, I Labiano, A Arbelaiz, et al.
Pageof 21